Despite the benefits of GLP-1 RAs, they are not commonly prescribed in people living with T2DM and CKD
KLOW is GLOW plus a fourth peptide, KPV a small anti-inflammatory tripeptide derived from a fragment of alpha-melanocyte-stimulating hormone (-MSH)
The SURPASS-4 trial is the first randomized controlled trial assessing cardiovascular outcomes with Tirzepatide [45]
IV blends of glutathione, biotin, high-dose vitamin C, Zinc, B vitamins, and more
This is precisely why the FDA has not approved BPC-157 for human use, and why honest providers like BlueWater make this distinction clear upfront
Living with a complex chronic illness like Long COVID, ME/CFS, or dysautonomia often feels like a full-time job that you never applied for